The Technical Analyst
Select Language :
Eledon Pharmaceuticals, [ELDN]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Eledon Pharmaceuticals, Price, Forecast, Insider, Ratings, Fundamentals & Signals

Eledon Pharmaceuticals, is listed at the  Exchange

-3.29% $2.06

America/New_York / 28 mar 2024 @ 16:00


Eledon Pharmaceuticals,: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 49.85 mill
EPS: -5.44
P/E: -0.380
Earnings Date: Mar 27, 2024
SharesOutstanding: 24.20 mill
Avg Daily Volume: 0.0764 mill
RATING 2024-03-28
B
Neutral
RATINGS
Rating CashFlow: Strong Buy
Return On Equity: Sell
Return On Asset: Sell
DE: Sell
P/E: Sell
Price To Book: Neutral
QUARTER GROWTHS
2/223/224/221/232/233/23
Revenuen/an/an/an/an/an/a
Gr.Profitn/an/an/an/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.380 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.06x
Company: PE -0.380 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$3.90
(89.15%) $1.837
Date: 2024-03-28
Expected Trading Range (DAY)

$ 1.940 - 2.18

( +/- 5.83%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2023-10-02 Robinson James A. Jr. Buy 150 437 Stock Option (Right to Buy)
2023-10-02 Kirk Allan Buy 150 437 Stock Option (Right to Buy)
2023-10-01 Robinson James A. Jr. Buy 0
2023-10-02 Kirk Allan Buy 0
2023-05-05 Bvf Partners L P/il Buy 3 084 090 Warrants to Purchase Common Stock
INSIDER POWER
100.00
Last 95 transactions
Buy: 17 704 764 | Sell: 1 858 032

Forecast: 16:00 - $2.09

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $2.09
Forecast 2: 16:00 - $2.09
Forecast 3: 16:00 - $2.09
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $2.06 (-3.29% )
Volume 0.0414 mill
Avg. Vol. 0.0764 mill
% of Avg. Vol 54.20 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Eledon Pharmaceuticals, Inc.

Last 12 Months

Last 12 months chart data with high, low, open and close for Eledon Pharmaceuticals, Inc.

RSI

Intraday RSI14 chart for Eledon Pharmaceuticals, Inc.

Last 10 Buy & Sell Signals For ELDN

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Eledon Pharmaceuticals, Inc.

ELDN

Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that is a molecule expressed on the surface of human immune system T cells, which is in Phase 2a clinical trials for the treatment of ALS, and Phase 2 clinical trials in islet cell transplantation for the treatment of type 1 diabetes. The company was formerly known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals, Inc. in January 2021. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California.

Last 10 Buy Signals

Date Signal @
ALCXUSDMar 29 - 01:19$33.72
HBTCUSDMar 29 - 01:0837 602
ARUSDMar 29 - 01:07$41.90
NULSUSDMar 29 - 01:02$0.868
WAVESUSDMar 29 - 01:01$3.83
NEXOUSDMar 29 - 01:001.330
YFIIUSDMar 29 - 00:58$616.31
WAMPLUSDMar 29 - 00:5830.04
XCHUSDMar 29 - 00:58$40.85
SSVUSDMar 29 - 00:5961.02

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.